Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer

Overview of attention for article published in Drug Design, Development and Therapy, March 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,882 followers.

Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer https://t.co/p256prk6Yu

Reply Repost Favourite

Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer. https://t.co/Z8jK2k3wyr

Reply Repost Favourite